Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
memo - Magazine of European Medical Oncology
Published in: memo - Magazine of European Medical Oncology 1/2019

01-03-2019 | Esophageal Cancer | editorial

Progress in the multidisciplinary management of esophageal cancer: what are the latest developments?

Author: PD Dr. Thomas Winder, PhD

Published in: memo - Magazine of European Medical Oncology | Issue 1/2019

Login to get access

Excerpt

In the last decade strategies to improve overall survival of patients with esophageal cancer have changed. To summarize this dynamic development the topic for the authors of this mini-review series of esophageal cancer was to highlight the latest developments in the multidisciplinary treatment of patients with esophageal cancer. …
Metadata
Title
Progress in the multidisciplinary management of esophageal cancer: what are the latest developments?
Author
PD Dr. Thomas Winder, PhD
Publication date
01-03-2019
Publisher
Springer Vienna
Published in
memo - Magazine of European Medical Oncology / Issue 1/2019
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-019-0476-7

Other articles of this Issue 1/2019

memo - Magazine of European Medical Oncology 1/2019 Go to the issue

review

Toxicities in B‑cell non-Hodgkin lymphoma—new agents, new pitfalls

short review

Therapeutic endoscopic strategies in early esophageal cancer and dysplastic Barrett’s epithelium

educational

Educational no. 4: PCR-based methods

short review

A case report of pseudo-progression after pembrolizumab in metastatic gastric cancer and a review of immunotherapy in gastroesophageal tumors

original report

Changes in patients’ quality of life during radiotherapy and 1 month after treatment

review

Minimally invasive esophagectomy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits